Inderbir S. Gill, M.D., M.Ch.

Inderbir S. Gill, M.D., M.ChChairman & Professor, Catherine & Joseph Aresty Department of Urology
Executive Director, USC Institute of Urology
Associate Dean (Clinical Innovation)
Keck School of Medicine, University of Southern California
Los Angeles, California USA

Dr Gill joined the University of Southern California (USC) in mid-2009 as chairman & professor, department of urology. Prior to this, he was chairman & professor, department of urology at Cleveland Clinic, Cleveland, OH, where he was on faculty for 12 years (1997-2009).

During his 4 years at USC, USC urology has seen dramatic growth in scientific stature, clinical volumes and financial productivity. As a result, USC urology has progressed in U.S. News & World Report rankings from not being ranked in the ‘Top 50’ prior to 2009 to #20 in 2014.

His academic track record includes over 551 peer-reviewed scientific papers, 10 text-books and editorial board of 9 urologic journals. Funded by the NCI, he has been invited for over 450 visiting professorships, invited lectures and live surgery demonstrations world-wide. He is elected to the prestigious American Association of Genito-Urinary Surgeons (2003) and the Clinical Society of AAGUS (2009).

Dr Gill has received many honors. In 2005, the President of India awarded him the Dr. B. C. Roy National Award for Eminent Medical Person. In 2006, he was awarded the St. Paul’s Medal by the British Urological Association (BAUS) for 2006, the highest honor that can be bestowed by the BAUS. He has been named honorary Fellow of the Royal College of Surgeons of England. In 2006, he was President of the 24th World Congress of Endourology and SWL, and organized in Cleveland one of the most successful world congresses to date, with more than 1700 attendees from 62 countries. He was awarded the “USC Presidential Medallion” for 2013, the highest annual academic honor that USC can bestow from amongst the 40,000+ faculty/students from all 19 of USC’s schools. He has been listed amongst “Best Doctors in America” for several years now. His minimally invasive team has won over 35 best abstract awards at various annual meetings of the AUA and other urologic societies over the past 5-7 years.

Dr. Gill’s primary focus is advanced robotic urologic oncologic surgery, with one of the world’s largest aggregate robotic/laparoscopic experiences in approx 9,000 cases in the United States. An acknowledged world leader in robotic/laparoscopic partial nephrectomy for renal cancer, he and his team have performed this procedure in over 2,500 patients, the world’s largest series. His team’s many scientific innovations in robotic & laparoscopic oncologic surgery have generated world-leading clinical series of radical cystectomy with intra-corporeal urinary diversion (n=200+), radical prostatectomy (n= 6,000+) and renal cryoablation. His team is actively developing flexible robotics, natural orifice and single-port laparoscopic surgery in urology, innovative concepts towards scar-free surgery. Over the past 3 years, Dr Gill and his team are focusing on developing novel image-guided targeted biopsy and lesion-specific focal therapy treatments for prostate cancer.

In Google “Top Authors in Urology”, Dr Gill is ranked #1 in the field of Urology Peer-reviewed papers: 513, Citations: 8452, H-index: 48, G-index: 72 (Google “Top Authors in Urology”) (accessed January 12, 2014).

Listed in the 2014 Thomson Reuters “The World’s Most Influential Scientific Minds” Reuters assessed papers indexed between 2002 and 2012 in 21 fields of study. Reuters tracked authors who published numerous articles ranking among the top 1 percent of the most cited in their fields in the year of publication. The documents represent research that the scientific community has judged to be the most significant and useful. Dr Gill was one of only 2 urologists to be so listed.